Pancreatic Cancer Trial: 28.9 months OS in AMPLIFY-201 Immunotherapy 2 Mins Read OncologyTube brings you an exclusive look at the AMPLIFY-201 Phase 1 trial. Furthermore, this study highlights ELI-002 2P, a lymph…
